염색체 불안정성은 대장암 간 전이 절제 후 베바시주맙의 예후 및 효능과 관련이 있다

Li 등(월,)이 이 문제를 연구하였다.

www.synapsesocial.com/papers/68e58ff8b6db64358752ba85 — DOI: https://doi.org/10.1080/07853890.2024.2396559

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Interleukin-6 signaling pathway in targeted therapy for cancer· 2012 · 692 citations
2. Clinical relevance of serum vascular endothelial growth factor and Interleukin-6 in patients with colorectal cancer· 2011 · 40 citations
3. AP4 suppresses DNA damage, chromosomal instability and senescence via inducing MDC1/Mediator of DNA damage Checkpoint 1 and repressing MIR22HG/miR-22-3p· 2022 · 63 citations
4. Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions· 2014 · 732 citations
5. Colorectal cancer statistics, 2023· 2023 · 3,742 citations